Hikma Pharmaceuticals Plc Director/PDMR Shareholding (0225P)

TIDMHIK

RNS Number : 0225P

Hikma Pharmaceuticals Plc

23 May 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                   John Castellani 
---  ---------------------  ------------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status        Non-Executive Director 
---  ---------------------  ------------------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ------------------------------------- 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  ------------------------------------------------------------ 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each (Shares) 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ------------------------------------- 
 b)   Nature of              Market purchase of 1,000 Ordinary 
       the transaction        Shares by Brown Advisory Investment 
                              Management Firm for and on behalf 
                              of John and Therese Castellani. 
---  ---------------------  ------------------------------------- 
 c)   Price(s) and           Price(s): GBP13.7695 
       volume(s)              Volume(s): 1,000 
---  ---------------------  ------------------------------------- 
 d)   Aggregated 
       information             1,000 
        *    Volume           GBP13,769.50 
 
 
        *    Price 
---  ---------------------  ------------------------------------- 
 e)   Date of the            22 May 2018 
       transaction 
---  ---------------------  ------------------------------------- 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  -------------------------------------

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGCGDUCBDBGIX

(END) Dow Jones Newswires

May 23, 2018 05:20 ET (09:20 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024